Category: Danaher Corp.Syndicate content

JNJ looks to bolster "subscale" cardiovascular business | The week in medtech M&A

July 23, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter

Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere

July 16, 2014 by Brad Perriello

YYmeta

Siemens sells clinical microbiology biz to Beckman Coulter

July 17, 2014 by Arezu Sarvestani

Beckman Coulter picks up Siemens Healthcare Diagnostics' clinical microbiology business in a closed-doors deal.

Siemens sells clinical microbiology biz to Beckman Coulter

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Danaher, Blackstone join forces in hunt for J&J diagnostics unit

November 8, 2013 by Brad Perriello

Danaher Corp. and private equity behemoth Blackstone are joining forces in the hunt for Johnson & Johnson's Ortho Clinical Diagnostics unit, anonymous sources tell Reuters.

Report: Danaher, Blackstone join forces in hunt for J&J diagnostics unit

Danaher climbs on Q3 numbers

October 17, 2013 by Brad Perriello

Shares of Danaher Corp. rise after it beats Wall Street's earnings forecast and affirms its outlook for the rest of the year.

Danaher climbs on Q3 numbers

Danaher (NYSE:DHR) shares gained today after the conglomerate shattered Wall Street's 3rd-quarter earnings expectations and affirmed its outlook for the balance of 2013.

Johnson & Johnson shops Ortho Clinical Diagnostics unit

September 9, 2013 by Brad Perriello

Johnson & Johnson puts its Ortho Clinical Diagnostics blood testing business on the auction block.

Johnson & Johnson shops Ortho Clinical Diagnostics unit

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Danaher slides on narrowed outlook

July 18, 2013 by Brad Perriello

Share of Danaher Corp. are down today after the company reports 2nd-quarter results and narrows its earnings forecast for the rest of the year.

Danaher slides on narrowed outlook

Danaher (NYSE:DHR) shares are down today on a narrowed earnings outlook for the rest of the year, after the conglomerate reported modest 2nd-quarter sales and earnings growth.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Danaher shares drop as Q1 earnings fall short of expectations

April 18, 2013 by Arezu Sarvestani

Danaher posts adjusted per-share earnings just a penny shy of Wall Street's consensus estimate, and the company's shares lose 2.5%.

Danaher logo

Washington-based Danaher (NYSE:DHR) posted gains in its 1st-quarter 2013 sales and profits, but fell a penny short of analysts' earning expectations for the 3 months ended March 29, 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp